IL-17 inhibitor-associated inflammatory bowel disease: A study based on literature and database analysis

IL-17 inhibitor-associated inflammatory bowel disease: A study based on literature and database analysis

Objective: Few real-world studies have shown clear association between interleukin (IL)-17 inhibitors and inflammatory bowel disease (IBD) onset. This study investigated the reporting prevalence and evaluated the clinical features and management of IL-17 inhibitor-related IBD events.Methods: We used...

Full description

Bibliographic Details
Main Authors: Zhenzhen Deng, Shengfeng Wang, Cuifang Wu, Chunjiang Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Pharmacology
Subjects:
IL-17 inhibitors
inflammatory bowel disease
FAERS database
pharmacovigilance
drug safety
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1124628/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2023.1124628/full

Similar Items